Results 421-440 of 1,056,671 for in 'Dáil debates' OR in 'Committee meetings' (speaker:Cyprian Brady OR speaker:Martin Browne OR speaker:Paul McAuliffe OR speaker:Paschal Donohoe OR speaker:Thomas Pringle OR speaker:Charlie McConalogue OR speaker:Holly Cairns OR speaker:Michael Creed)

Ceisteanna Eile - Other Questions: Disability Services (24 Oct 2024)

Roderic O'Gorman: I cannot disagree with anything the Deputy said in terms of the challenge the significant level of vacancy poses for the CDNTs all over the country and their ability to deliver crucial interventions for children and the subsequent improvements in quality of life for families. The next Government will look at the progressing disabilities model and have an opportunity to make decisions. We...

Ceisteanna Eile - Other Questions: Disability Services (24 Oct 2024)

Pauline Tully: We have been hearing about a recruitment campaign for quite some time. The progressing disability model was drawn up in 2013 or 2014, I think. At that time, workforce planning was not done and we now do not have sufficient therapists. I acknowledge it will take time to educate enough therapists but there is no guarantee they will work in disability services. There are many other areas...

Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)

Paul McAuliffe: I thank everyone for coming in. We are always trying to use our time in the meeting. We are here to do a body of work. Sometimes for us it can be frustrating revisiting topics such as the impacts of poverty, intergenerational trauma and the concentration of this in disadvantaged communities. The reason it can be frustrating is because many of the people who are here at this committee are...

Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)

Paul McAuliffe: That has an impact on retention and recruitment.

Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)

Paul McAuliffe: I hear Mr. D’Arcy there.

Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)

Paul McAuliffe: The question was about youth justice and that project.

Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)

Paul McAuliffe: Are there any organisations that are funded by youth justice?

Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)

Paul McAuliffe: In theory, the UBU project is for general youth work and the youth justice system is for more targeted youth work. On young people being referred to services through the Garda referral process, what is Mr. Ducque's experience of criminal association with addiction or involvement in the sale or distribution of drugs? How does that get in the way of working with young people? Does it get in...

Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)

Paul McAuliffe: They are picking up too many charges.

Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)

Paul McAuliffe: It is an opportunity to engage.

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Paul McAuliffe: I acknowledge the Cathaoirleach's new position. I have no doubt but that she will continue the good work of the previous Chair in chairing this committee and doing it in a cross-party way. Our work in this committee is very important, but so is the way we do our work. It is important and different from other committees. I acknowledge this point. I thank Mr. Gloster and all the team for...

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Paul McAuliffe: I saw a figure regarding the outpatient waiting lists having been reduced by 50,000 people. Mr. Gloster is saying this is a real reduction rather than a validation exercise.

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Paul McAuliffe: Will Mr. Gloster repeat that figure?

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Paul McAuliffe: I accept that point. The experience just shone a light on the outpatients waiting list for me.

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Paul McAuliffe: We do not know, but this may be the last or the second last meeting of this committee. It will certainly be the last meeting during this Dáil when Mr. Gloster will be before us anyway.

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Paul McAuliffe: I am very much cognisant of the volume of money associated with this hearing. We are talking about €23.5 billion. Many Government Departments could be folded into that figure. In 2019, the figure was €16 billion. Essentially, there has been a 46% increase in the funding of the HSE over the past four years, that is, the lifetime of this Government. In 60 seconds, can Mr....

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Paul McAuliffe: I would love to explore that point more but I just do not have the time. Turning to the non-compliant procurement, this is the first thing we look at in this committee. The HSE estimated that the total expenditure on goods and services subject to procurement rules was €4.2 billion. Again, this amount is multiples of an entire Government Department in some cases. The idea that...

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Paul McAuliffe: When the HSE did the self-assessed audit, there was a very significant percentage of either non-co-operation or where you could not identify the purchaser. The figure of 12% actually could be higher.

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Paul McAuliffe: Just to return to that point, Mr. Mulvany is saying the figure of 12% does include the 13% of invoices within the scope of the exercise where either the manager responsible could not be identified or where the manager failed to respond to the exercise. He is saying that 13% is deemed non-compliant and is included in the 12%.